Pathogenic bacteria cause the deaths of millions of people
every
year. With the development of antibiotics, hundreds and thousands
of people’s lives have been saved. Nevertheless, bacteria can
develop resistance to antibiotics, rendering them insensitive to antibiotics
over time. Peptides containing specific amino acids can be used as
antibacterial agents; however, they can be easily degraded by proteases in vivo. To address these issues, branched peptide dendrimers
are now being considered as good antibacterial agents due to their
high efficacy, resistance to protease degradation, and low cytotoxicity.
The ease with which peptide dendrimers can be synthesized and modified
makes them accessible for use in various biological and nonbiological
fields. That is, peptide dendrimers hold a promising future as antibacterial
agents with prolonged efficacy without bacterial resistance development.
Their in vivo stability and multivalence allow them
to effectively target multi-drug-resistant strains and prevent biofilm
formation. Thus, it is interesting to have an overview of the development
and applications of peptide dendrimers in antibacterial research,
including the possibility of employing machine learning approaches
for the design of AMPs and dendrimers. This review summarizes the
synthesis and applications of peptide dendrimers as antibacterial
agents. The challenges and perspectives of using peptide dendrimers
as the antibacterial agents are also discussed.